These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 15806137)

  • 1. Characterization of lymphoblast mitochondria from patients with Barth syndrome.
    Xu Y; Sutachan JJ; Plesken H; Kelley RI; Schlame M
    Lab Invest; 2005 Jun; 85(6):823-30. PubMed ID: 15806137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
    Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
    J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography.
    Acehan D; Xu Y; Stokes DL; Schlame M
    Lab Invest; 2007 Jan; 87(1):40-8. PubMed ID: 17043667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphokinome Analysis of Barth Syndrome Lymphoblasts Identify Novel Targets in the Pathophysiology of the Disease.
    Agarwal P; Cole LK; Chandrakumar A; Hauff KD; Ravandi A; Dolinsky VW; Hatch GM
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30002286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipid abnormalities in children with Barth syndrome.
    Schlame M; Kelley RI; Feigenbaum A; Towbin JA; Heerdt PM; Schieble T; Wanders RJ; DiMauro S; Blanck TJ
    J Am Coll Cardiol; 2003 Dec; 42(11):1994-9. PubMed ID: 14662265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-oleoylethanolamide treatment of lymphoblasts deficient in Tafazzin improves cell growth and mitochondrial morphology and dynamics.
    Chan JZ; Fernandes MF; Steckel KE; Bradley RM; Hashemi A; Groh MR; Sciaini G; Stark KD; Duncan RE
    Sci Rep; 2022 Jun; 12(1):9466. PubMed ID: 35676289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-chain fatty acid oxidation and respiratory complex I deficiencies distinguish Barth Syndrome from idiopathic pediatric cardiomyopathy.
    Chatfield KC; Sparagna GC; Specht KS; Whitcomb LA; Omar AK; Miyamoto SD; Wolfe LM; Chicco AJ
    J Inherit Metab Dis; 2022 Jan; 45(1):111-124. PubMed ID: 34821394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tafazzin deficiency causes substantial remodeling in the lipidome of a mouse model of Barth Syndrome cardiomyopathy.
    Hachmann M; Gülcan G; Rajendran R; Höring M; Liebisch G; Bachhuka A; Kohlhaas M; Maack C; Ergün S; Dudek J; Karnati S
    Front Mol Med; 2024; 4():1389456. PubMed ID: 39086433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiolipin Remodeling Defects Impair Mitochondrial Architecture and Function in a Murine Model of Barth Syndrome Cardiomyopathy.
    Zhu S; Chen Z; Zhu M; Shen Y; Leon LJ; Chi L; Spinozzi S; Tan C; Gu Y; Nguyen A; Zhou Y; Feng W; Vaz FM; Wang X; Gustafsson AB; Evans SM; Kunfu O; Fang X
    Circ Heart Fail; 2021 Jun; 14(6):e008289. PubMed ID: 34129362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barth syndrome cardiomyopathy: targeting the mitochondria with elamipretide.
    Sabbah HN
    Heart Fail Rev; 2021 Mar; 26(2):237-253. PubMed ID: 33001359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restoration of mitophagy ameliorates cardiomyopathy in Barth syndrome.
    Zhang J; Liu X; Nie J; Shi Y
    Autophagy; 2022 Sep; 18(9):2134-2149. PubMed ID: 34985382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiolipin transacylase, tafazzin, associates with two distinct respiratory components providing insight into Barth syndrome.
    Claypool SM; Boontheung P; McCaffery JM; Loo JA; Koehler CM
    Mol Biol Cell; 2008 Dec; 19(12):5143-55. PubMed ID: 18799610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barth Syndrome Cardiomyopathy: An Update.
    Pang J; Bao Y; Mitchell-Silbaugh K; Veevers J; Fang X
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promotion of plasmalogen biosynthesis reverse lipid changes in a Barth Syndrome cell model.
    Bozelli JC; Lu D; Atilla-Gokcumen GE; Epand RM
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158677. PubMed ID: 32126285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lipid environment modulates cardiolipin and phospholipid constitution in wild type and tafazzin-deficient cells.
    Oemer G; Koch J; Wohlfarter Y; Lackner K; Gebert REM; Geley S; Zschocke J; Keller MA
    J Inherit Metab Dis; 2022 Jan; 45(1):38-50. PubMed ID: 34494285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiolipin remodeling by TAZ/tafazzin is selectively required for the initiation of mitophagy.
    Hsu P; Liu X; Zhang J; Wang HG; Ye JM; Shi Y
    Autophagy; 2015 Apr; 11(4):643-52. PubMed ID: 25919711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barth syndrome: cellular compensation of mitochondrial dysfunction and apoptosis inhibition due to changes in cardiolipin remodeling linked to tafazzin (TAZ) gene mutation.
    Gonzalvez F; D'Aurelio M; Boutant M; Moustapha A; Puech JP; Landes T; Arnauné-Pelloquin L; Vial G; Taleux N; Slomianny C; Wanders RJ; Houtkooper RH; Bellenguer P; Møller IM; Gottlieb E; Vaz FM; Manfredi G; Petit PX
    Biochim Biophys Acta; 2013 Aug; 1832(8):1194-206. PubMed ID: 23523468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiolipin deficiency leads to the destabilization of mitochondrial magnesium channel MRS2 in Barth syndrome.
    Joshi A; Gohil VM
    Hum Mol Genet; 2023 Dec; 32(24):3353-3360. PubMed ID: 37721533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between cardiolipin and plasmalogens in Barth syndrome.
    Bozelli JC; Epand RM
    J Inherit Metab Dis; 2022 Jan; 45(1):99-110. PubMed ID: 34655242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of mitochondrial oxodicarboxylate carrier (ODC1) preserves oxidative phosphorylation in a yeast model of Barth syndrome.
    de Taffin de Tilques M; Tribouillard-Tanvier D; Tétaud E; Testet E; di Rago JP; Lasserre JP
    Dis Model Mech; 2017 Apr; 10(4):439-450. PubMed ID: 28188263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.